In particular, a marked reduction of tumor volume was observed in a syngeneic murine model of melanoma after treatment with the anti-human VEGFR-1 mAb D16F7, that recognizes also the murine and rat protein [125]. The gene discussed is FLT1; the disease is melanoma.